nVerses Capital’s Usana Health Sciences USNA Stock Holding History

nVerses Capital’s Portfolio USNA Stock Details USNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-2,300	Closed	-$112K	–	1219
2024 Q1	$112K	Buy	+2,300	New	+$113K	0.27%	151

Other funds holding USNA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

nVerses Capital's USNA Position: Q2 2024 in Review

nVerses Capital sold out of Usana Health Sciences (USNA) in Q2 2024, closing a stake of 2,300 shares — an estimated $112K sold.

nVerses Capital first reported a position in USNA in Q1 2024 and held it in 1 quarter. The position peaked at $112K in Q1 2024. 154 funds tracked by Wall St. Rank hold USNA as of Q2 2024.

nVerses Capital reported no remaining Usana Health Sciences position as of Q2 2024 after selling out during the quarter.
nVerses Capital sold 2,300 Usana Health Sciences shares in Q2 2024, an estimated $112K.
nVerses Capital first reported a position in Usana Health Sciences in Q1 2024 and held it in 1 quarter.
nVerses Capital's Usana Health Sciences position peaked at $112K in Q1 2024.
154 funds tracked by Wall St. Rank held Usana Health Sciences as of Q2 2024.

Based on nVerses Capital's 13F filing for Q2 2024, filed 31 Jul 2024.